Nonprofit pharmaceutical company has delivered nearly $44 million in savings since 2022 LEHI, Utah, June 25, 2026 /PRNewswire/ — CivicaScript’s transparent, nonprofit business model saved patients and payer members more than $16 million in 2025 after they switched to its low-cost generic…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Q3 revenue growth of 12% year-over-year Q3 net income of $30.6 million and non-GAAP net income of $67.8 million Q3 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA […]
Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia […]
DRAPER, Utah, Sept. 11, 2025 /PRNewswire/ — Nexus Spine is excited to share pilot study results of a comparative radiographic assessment of ACDF outcomes in a series of patients who were selected for common risk […]
Copyright © 2026 Biotech Networks
